Team Helene Alexanderson

Publikationer

All publications from group members

• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;65:152379

  Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies - A longitudinal study.

  Lodin K; Espinosa-Ortega F; Dastmalchi M; Vencovsky J; Andersson H; Chinoy H; Lilleker JB; Shinjo SK; Maurer B; Griger Z; Ceribelli A; Torres-Ruiz J; Mercado M V-D; Leonard D; Alexanderson H; Lundberg IE; MyoNet Registry Study Group
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;64:152339

  Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.

  Saygin D; DiRenzo D; Raaphorst J; de Groot I; Bingham CO; Lundberg IE; Regardt M; Sarver C; de Visser M; Maxwell LJ; Beaton D; Kim JY; Needham M; Alexanderson H; Christopher-Stine L; Mecoli CA; Park JK; OMERACT Myositis Working Group
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2024;42(2):207-212

  Collaborative research in myositis-related disorders: MIHRA, a global shared community model.

  Saketkoo LA; Paik JJ; Alexanderson H; Dimachkie MM; Ernste FC; Naddaf E; Shafranski B; Gupta L; Mecoli CA; Saygin D; Albayda J; Basharat P; Day JA; Valenzuela A; Bromley R; de Groot I; Edison SE; Lanis A; Lood C; Regardt M; Yi BY; Benitez AC; Chinoy H; Christopher-Stine L; Isenberg DA; Lang B; Oddis CV; van Royen A; Vencovsky J; Werth VP; Machado PM
• Review: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2024;42(2):413-424

  Mental health in paediatric and adult myositis-related diseases: current state of research, interventions, and future steps from the MIHRA Psychological Impact Scientific Working Group.

  Lanis A; Alexanderson H; Ardalan K; Edison S; Graham CD; de Groot I; Gupta L; Kim S; Knight AM; Kobert L; Livermore P; Lood C; Pilkington C; Regardt M; Rubinstein TB; Shenoi S; Turnier L; Voet NBM; Wahezi DM; Saketkoo LA
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;:ard-2023-224416

  EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.

  Parodis I; Girard-Guyonvarc'h C; Arnaud L; Distler O; Domján A; Van den Ende CHM; Fligelstone K; Kocher A; Larosa M; Lau M; Mitropoulos A; Ndosi M; Poole JL; Redmond A; Ritschl V; Alexanderson H; Sjöberg Y; von Perner G; Uhlig T; Varju C; Vriezekolk JE; Welin E; Westhovens R; Stamm TA; Boström C
• Editorial comment: RHEUMATOLOGY. 2023;:kead331

  Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis.

  Saketkoo LA; Valenzuela A; Kim S; McCann LJ; Lood C; Wahezi DM; Werth VP; Yi B; Alexanderson H; Maillard S; Pilkington C; Fligelstone K; Limbach B; Orandi AB; Regardt M; Russell A-M; Davuluri S; deGroot I; Ernste F; Paik JJ; von Muhlen CA; Dimachkie MM; Machado PM; Naddaf E; Zulian F; Chung L; and International Myositis Assessment and Clinical
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;58:152111

  Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.

  DiRenzo D; Saygin D; de Groot I; Bingham Iii CO; Lundberg IE; Needham M; Park JK; Regardt M; Sarver C; Song YW; Maxwell L; Beaton D; de Visser M; Christopher-Stine L; Mecoli CA; Alexanderson H
• Article: PROSTHETICS AND ORTHOTICS INTERNATIONAL. 2022;46(3):232-238

  Low health-related quality of life in adult individuals with multiple limb deficiencies compared with population-based reference values.

  Alexanderson H; Frimore L; Espinosa F; Wikström M; Stockselius A
• Article: ARTHRITIS CARE & RESEARCH. 2022;74(3):468-477

  Factors Associated With Treatment Response in Patients With Idiopathic Inflammatory Myopathies: A Registry-Based Study.

  Espinosa-Ortega F; Holmqvist M; Dastmalchi M; Lundberg IE; Alexanderson H
• Article: FRONTIERS IN PHARMACOLOGY. 2022;13:979788

  World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease.

  Saketkoo LA; Escorpizo R; Varga J; Keen KJ; Fligelstone K; Birring SS; Alexanderson H; Pettersson H; Chaudhry HA; Poole JL; Regardt M; LeSage D; Sarver C; Lanario J; Renzoni E; Scholand MB; Lammi MR; Kowal-Bielecka O; Distler O; Frech T; Shapiro L; Varju C; Volkmann ER; Bernstein EJ; Drent M; Obi ON; Patterson KC; Russell A-M; Global Fellowship on Rehabilitation and Exercise i
• Review: BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2021;35(3):101707

  A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

  Saketkoo LA; Frech T; Varjú C; Domsic R; Farrell J; Gordon JK; Mihai C; Sandorfi N; Shapiro L; Poole J; Volkmann ER; Lammi M; McAnally K; Alexanderson H; Pettersson H; Hant F; Kuwana M; Shah AA; Smith V; Hsu V; Kowal-Bielecka O; Assassi S; Cutolo M; Kayser C; Shanmugam VK; Vonk MC; Fligelstone K; Baldwin N; Connolly K; Ronnow A; Toth B; Suave M; Farrington S; Bernstein EJ; Crofford LJ; Czirják L; Jensen K; Hinchclif M; Hudson M; Lammi MR; Mansour J; Morgan ND; Mendoza F; Nikpour M; Pauling J; Riemekasten G; Russell A-M; Scholand MB; Seigart E; Rodriguez-Reyna TS; Hummers L; Walker U; Steen V
• Review: BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2021;35(3):101695

  Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).

  Pettersson H; Alexanderson H; Poole JL; Varga J; Regardt M; Russell A-M; Salam Y; Jensen K; Mansour J; Frech T; Feghali-Bostwick C; Varjú C; Baldwin N; Heenan M; Fligelstone K; Holmner M; Lammi MR; Scholand MB; Shapiro L; Volkmann ER; Saketkoo LA
• Article: JOURNAL OF RHEUMATOLOGY. 2021;48(1):94-100

  Functional Index-3: A Valid and Reliable Functional Outcome Assessment Measure in Patients With Dermatomyositis and Polymyositis.

  Ernste FC; Chong C; Crowson CS; Kermani TA; Mhuircheartaigh ON; Alexanderson H
• Letter: LANCET RESPIRATORY MEDICINE. 2020;8(12):e90-e91

  An ode to the primal tonic of dance-congratulating the Life of Breath project.

  Saketkoo LA; Alexanderson H; Lammi MR; LeSage D; Jensen K; Scholand MB; Volkmann ER; Russell A-M
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2020;50(5):943-948

  Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group.

  Esfandiary T; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; de Visser M; Song YW; DiRenzo D; Bingham CO; Christopher-Stine L; Mecoli CA
• Article: MUSCULOSKELETAL CARE. 2020;18(2):150-160

  Experiences of physical activity and exercise in individuals with systemic sclerosis: A qualitative study.

  Pettersson H; Nordin A; Svenungsson E; Alexanderson H; Boström C
• Review: BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2020;34(2):101547

  Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus - A systematic literature review.

  Alexanderson H; Boström C
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2020;38(1):42-49

  Features of repeated muscle biopsies and phenotypes of monocytes in paired blood samples and clinical long-term response to treatment in patients with idiopathic inflammatory myopathy: a pilot study.

  Tang Q; Gheorghe KR; Zhang X-M; Lindroos E; Alexanderson H; Wick C; Bruton M; Fernandes-Cerqueira C; Harris RA; Nennesmo I; Lundberg IE
• Article: RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2019;45(4):569-581

  Idiopathic Inflammatory Myopathies.

  Vencovský J; Alexanderson H; Lundberg IE
• Article: JOURNAL OF PATHOLOGY. 2019;249(2):215-226

  Mitochondrial dysfunction and role of harakiri in the pathogenesis of myositis.

  Boehler JF; Horn A; Novak JS; Li N; Ghimbovschi S; Lundberg IE; Alexanderson H; Alemo Munters L; Jaiswal JK; Nagaraju K
• Published conference paper: JOURNAL OF RHEUMATOLOGY. 2019;46(10):1351-1354

  OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies.

  Regardt M; Mecoli CA; Park JK; de Groot I; Sarver C; Needham M; de Visser M; Shea B; Bingham CO; Lundberg IE; Song YW; Christopher-Stine L; Alexanderson H
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(6):858-860

  Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies.

  Espinosa-Ortega F; Holmqvist M; Alexanderson H; Storfors H; Mimori T; Lundberg IE; Rönnelid J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(2):141-148

  Muscle endurance, strength, and active range of motion in patients with different subphenotypes in systemic sclerosis: a cross-sectional cohort study.

  Pettersson H; Boström C; Bringby F; Walle-Hansen R; Jacobsson L; Svenungsson E; Nordin A; Alexanderson H
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2019;89(1):e12732

  Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis.

  Tang Q; Ramsköld D; Krystufkova O; Mann HF; Wick C; Dastmalchi M; Lakshmikanth T; Chen Y; Mikes J; Alexanderson H; Achour A; Brodin P; Vencovsky J; Lundberg IE; Malmström V
• Article: JOURNAL OF RHEUMATOLOGY. 2019;46(1):106-111

  Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study.

  Mecoli CA; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; Shea B; de Visser M; Song YW; Bingham CO; Christopher-Stine L
• Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):83

  Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.

  Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson P-J; Lundberg IE; Korotkova M
• Article: JOURNAL OF RHEUMATOLOGY. 2018;45(4):538-546

  Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.

  Alexanderson H; Regardt M; Ottosson C; Alemo Munters L; Dastmalchi M; Dani L; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(1):55-62

  Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial.

  Tjärnlund A; Tang Q; Wick C; Dastmalchi M; Mann H; Tomasová Studýnková J; Chura R; Gullick NJ; Salerno R; Rönnelid J; Alexanderson H; Lindroos E; Aggarwal R; Gordon P; Vencovsky J; Lundberg IE
• Review: CURR TREATM OPT RHEUMATOL. 2018;4(4):289-298

  Exercise in Myositis.

  Alexanderson H
• Article: BMC RESEARCH NOTES. 2017;10(1):687

  The McMaster Toronto Arthritis patient preference questionnaire (MACTAR): a methodological study of reliability and minimal detectable change after a 6 week-period of acupuncture treatment in patients with rheumatoid arthritis.

  Brodin N; Grooten WJA; Stråt S; Löfberg E; Alexanderson H
• Review: MUSCULOSKELETAL CARE. 2017;15(4):316-323

  Aerobic and resistance exercise in systemic sclerosis: State of the art.

  de Oliveira NC; Portes LA; Pettersson H; Alexanderson H; Boström C
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2017;46(6):490-495

  Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls.

  Pettersson H; Åkerström A; Nordin A; Svenungsson E; Alexanderson H; Boström C
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2017;29(6):591-597

  Novel insights of disability assessment in adult myositis.

  Espinosa-Ortega HF; Moreno-Ramirez M; Alexanderson H
• Published conference paper: JOURNAL OF RHEUMATOLOGY. 2017;44(11):1683-1687

  Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.

  Park JK; Mecoli CA; Alexanderson H; Regardt M; Christopher-Stine L; Casal-Domínguez M; de Groot I; Sarver C; Lundberg IE; Bingham CO; Song YW
• Article: CLINICAL RHEUMATOLOGY. 2017;36(10):2289-2295

  Quality of life correlates with muscle strength in patients with dermato- or polymyositis.

  Poulsen KB; Alexanderson H; Dalgård C; Jacobsen S; Weile L; Diederichsen LP
• Article: JOURNAL OF AUTOIMMUNITY. 2017;78:46-56

  The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.

  Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Popovic Silwerfeldt K; Agerberth B; Lundberg IE; Wick C
• Article: PLOS ONE. 2017;12(8):e0183292

  Effect of endurance exercise on microRNAs in myositis skeletal muscle-A randomized controlled study.

  Boehler JF; Hogarth MW; Barberio MD; Novak JS; Ghimbovschi S; Brown KJ; Alemo Munters L; Loell I; Chen Y-W; Gordish-Dressman H; Alexanderson H; Lundberg IE; Nagaraju K
• Article: ARTHRITIS & RHEUMATOLOGY. 2016;68(7):1738-1750

  Endurance Exercise Improves Molecular Pathways of Aerobic Metabolism in Patients With Myositis.

  Munters LA; Loell I; Ossipova E; Raouf J; Dastmalchi M; Lindroos E; Chen Y-W; Esbjörnsson M; Korotkova M; Alexanderson H; Nagaraju K; Crofford LJ; Jakobsson P-J; Lundberg IE
• Review: JOURNAL OF INTERNAL MEDICINE. 2016;280(1):75-96

  Physical exercise as a treatment for adult and juvenile myositis.

  Alexanderson H
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):136

  Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents.

  Loell I; Raouf J; Chen Y-W; Shi R; Nennesmo I; Alexanderson H; Dastmalchi M; Nagaraju K; Korotkova M; Lundberg IE
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:80

  Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis.

  Pandya JM; Loell I; Hossain MS; Zong M; Alexanderson H; Raghavan S; Lundberg IE; Malmström V
• Article: JOURNAL OF RHEUMATOLOGY. 2016;43(1):169-176

  Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.

  van der Stap DKD; Rider LG; Alexanderson H; Huber AM; Gualano B; Gordon P; van der Net J; Mathiesen P; Johnson LG; Ernste FC; Feldman BM; Houghton KM; Singh-Grewal D; Kutzbach AG; Alemo Munters L; Takken T; International Myositis Assessment and Clinical Stu
• Article: JOURNAL OF RHEUMATOLOGY. 2015;42(12):2492-2495

  Patients' Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure - Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12.

  Regardt M; Basharat P; Christopher-Stine L; Sarver C; Björn A; Lundberg IE; Wook Song Y; Bingham CO; Alexanderson H
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2014;26(6):704-711

  Therapy of myositis: biological and physical.

  Lundberg IE; Vencovsky J; Alexanderson H
• Article: MUSCULOSKELETAL CARE. 2014;12(3):160-172

  Hand exercise intervention in patients with polymyositis and dermatomyositis: a pilot study.

  Regardt M; Schult M-L; Axelsson Y; Aldehag A; Alexanderson H; Lundberg IE; Henriksson EW
• Article: CURRENT RHEUMATOLOGY REPORTS. 2014;16(7):429

  New insights into the benefits of exercise for muscle health in patients with idiopathic inflammatory myositis.

  Alemo Munters L; Alexanderson H; Crofford LJ; Lundberg IE
• Article: JOURNAL OF RHEUMATOLOGY. 2014;41(6):1124-1132

  Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis -- a randomized controlled single-blinded study with a 2-year followup.

  Alexanderson H; Munters LA; Dastmalchi M; Loell I; Heimbürger M; Opava CH; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(5):913-920

  Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up.

  Zong M; Dorph C; Dastmalchi M; Alexanderson H; Pieper J; Amoudruz P; Barbasso Helmers S; Nennesmo I; Malmström V; Lundberg IE
• Article: JOURNAL OF RHEUMATOLOGY. 2014;41(3):581-592

  Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group.

  Alexanderson H; Del Grande M; Bingham CO; Orbai A-M; Sarver C; Clegg-Smith K; Lundberg IE; Song YW; Christopher-Stine L
• Article: BMC RESEARCH NOTES. 2014;7:86

  Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study.

  Alexanderson H; Bergegård J; Björnådal L; Nordin A
• Article: DISABILITY AND REHABILITATION. 2014;36(21):1762-1767

  Disabilities of importance for patients to improve--using a patient preference tool in rheumatoid arthritis.

  Alemo Munters L; Brodin N; Löfberg E; Stråt S; Alexanderson H
• Article: ARTHRITIS CARE & RESEARCH. 2013;65(12):1959-1968

  Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup.

  Alemo Munters L; Dastmalchi M; Andgren V; Emilson C; Bergegård J; Regardt M; Johansson A; Orefelt Tholander I; Hanna B; Lidén M; Esbjörnsson M; Alexanderson H
• Article: ARTHRITIS RESEARCH & THERAPY. 2013;15(4):R83

  Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis.

  Alemo Munters L; Dastmalchi M; Katz A; Esbjörnsson M; Loell I; Hanna B; Lidén M; Westerblad H; Lundberg IE; Alexanderson H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(8):1390-1399

  TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis.

  Zong M; Bruton JD; Grundtman C; Yang H; Li JH; Alexanderson H; Palmblad K; Andersson U; Harris HE; Lundberg IE; Westerblad H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(2):293-299

  Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis.

  Loell I; Alemo Munters L; Pandya J; Zong M; Alexanderson H; Fasth AE; Ståhl Hallengren C; Rådmark O; Lundberg IE; Jakobsson P-J; Korotkova M
• Article: JOURNAL OF RHEUMATOLOGY. 2012;39(11):2134-2141

  The Myositis Activities Profile -- initial validation for assessment of polymyositis/dermatomyositis in the USA.

  Alexanderson H; Reed AM; Ytterberg SR
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(6):1055-1063

  Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.

  Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
• Article: CURRENT RHEUMATOLOGY REPORTS. 2012;14(3):244-251

  Exercise in inflammatory myopathies, including inclusion body myositis.

  Alexanderson H
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2012;24(2):201-207

  Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies.

  Alexanderson H; Lundberg IE
• Article: ARTHRITIS CARE & RESEARCH. 2011;63 Suppl 11(0 11):S118-S157

  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

  Rider LG; Werth VP; Huber AM; Alexanderson H; Rao AP; Ruperto N; Herbelin L; Barohn R; Isenberg D; Miller FW
• Article: ISRN RHEUMATOLOGY. 2011;2011:463124-5

  Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis.

  Alemo Munters L; van Vollenhoven RF; Alexanderson H
• Article: RHEUMATOLOGY. 2011;50(3):578-585

  Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study.

  Regardt M; Welin Henriksson E; Alexanderson H; Lundberg IE
• Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2011;31(1):18-25

  Higher proportion of fast-twitch (type II) muscle fibres in idiopathic inflammatory myopathies - evident in chronic but not in untreated newly diagnosed patients.

  Loell I; Helmers SB; Dastmalchi M; Alexanderson H; Munters LA; Nennesmo I; Lindroos E; Borg K; Lundberg IE; Esbjörnsson M
• Article: MOLECULAR MEDICINE. 2010;16(11-12):455-464

  A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis.

  Nader GA; Dastmalchi M; Alexanderson H; Grundtman C; Gernapudi R; Esbjörnsson M; Wang Z; Rönnelid J; Hoffman EP; Nagaraju K; Lundberg IE
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2009;21(2):158-163

  Exercise effects in patients with adult idiopathic inflammatory myopathies.

  Alexanderson H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(12):1670-1677

  A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

  Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(11):1596-1602

  Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis.

  Korotkova M; Helmers SB; Loell I; Alexanderson H; Grundtman C; Dorph C; Lundberg IE; Jakobsson P-J
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2007;25(6 Suppl 47):153-158

  Disease-specific quality indicators, outcome measures and guidelines in polymyositis and dermatomyositis.

  Alexanderson H; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;57(7):1303-1310

  Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis.

  Dastmalchi M; Alexanderson H; Loell I; Ståhlberg M; Borg K; Lundberg IE; Esbjörnsson M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(10):1276-1283

  Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.

  Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
• Review: CURRENT RHEUMATOLOGY REPORTS. 2007;9(4):273-279

  Inflammatory muscle disease: clinical presentation and assessment of patients.

  Alexanderson H; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;57(5):768-777

  Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis.

  Alexanderson H; Dastmalchi M; Esbjörnsson-Liljedahl M; Opava CH; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;57(4):694-702

  Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial.

  Chung Y-L; Alexanderson H; Pipitone N; Morrison C; Dastmalchi M; Ståhl-Hallengren C; Richards S; Thomas EL; Hamilton G; Bell JD; Lundberg IE; Scott DL
• Review: NATURE CLINICAL PRACTICE RHEUMATOLOGY. 2007;3(5):282-290

  Technology insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies.

  Lundberg IE; Alexanderson H
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2007;25(6):S153-S158

  Disease-specific quality indicators, outcome measures and guidelines in polymyositis and dermatomyositis

  Alexanderson H; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;55(1):114-122

  Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis.

  Alexanderson H; Broman L; Tollbäck A; Josefson A; Lundberg IE; Stenström CH
• Review: CURRENT RHEUMATOLOGY REPORTS. 2005;7(2):115-124

  Exercise: an important component of treatment in the idiopathic inflammatory myopathies.

  Alexanderson H
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2005;17(2):164-171

  The role of exercise in the rehabilitation of idiopathic inflammatory myopathies.

  Alexanderson H; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2004;50(5):1586-1594

  Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.

  Ulfgren A-K; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
• Review: LAKARTIDNINGEN. 2003;100(36):2754-2759

  [Exercise is beneficial for patients with myositis. Both pharmaceuticals and physical activity should be included in the therapy of chronic rheumatic muscle inflammation].

  Lundberg IE; Alexanderson H; Arnardottir S; Borg K
• Article: JOURNAL OF REHABILITATION MEDICINE. 2003;35(1):31-35

  Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction.

  Arnardottir S; Alexanderson H; Lundberg IE; Borg K
• Article: JOURNAL OF RHEUMATOLOGY. 2002;29(11):2386-2392

  Development of the myositis activities profile--validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis.

  Alexanderson H; Lundberg IE; Stenström CH
• Article: ARTHRITIS & RHEUMATOLOGY. 2000;43(2):336-348

  Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.

  Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2000;29(5):295-301

  The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis.

  Alexanderson H; Stenström CH; Jenner G; Lundberg I
• Article: NEUROPEPTIDES. 1999;33(4):260-264

  Exercise and variations in neuropeptide concentrations in rheumatoid arthritis.

  Stenström CH; Alexanderson H; Lundberg I; Lundeberg T; Theodorsson E; Nisell R
• Article: RHEUMATOLOGY. 1999;38(7):608-611

  Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study.

  Alexanderson H; Stenström CH; Lundberg I
• Visa fler

Medlemmar och kontakt

Gruppledare

• Helene Alexanderson

  Adjungerad Lektor | Docent

  E-postadress helene.alexanderson@ki.se

Alla medlemmar i gruppen

• Helene Alexanderson

  Adjungerad Lektor | Docent

  E-postadress helene.alexanderson@ki.se
• Kristofer Andreasson

  Doktorand

  E-postadress kristofer.andreasson@ki.se
• Maryam Dastmalchi

  Anknuten till Undervisning/Handledning

  E-postadress maryam.dastmalchi@ki.se
• Fabricio Espinosa

  Anknuten till Forskning

  E-postadress fabricio.espinosa@ki.se
• 

  Angeles Shunashy Galindo-Feria

  Anknuten till Forskning

  E-postadress angeles.galindo.feria@ki.se
• 

  Begum Horuluoglu

  Biträdande Lektor

  E-postadress begum.horuluoglu@ki.se
• Valérie Leclair

  Doktorand

  E-postadress valerie.leclair@ki.se
• 

  Karin Lodin

  Anknuten till Forskning

  E-postadress karin.lodin@ki.se
• 

  Ingrid Lundberg

  Professor | Docent

  E-postadress ingrid.lundberg@ki.se
• Yuebei Luo

  Anknuten till Forskning

  E-postadress yuebei.luo@ki.se
• Maho Nakazawa

  Postdoktorala Studier

  E-postadress maho.nakazawa@ki.se
• Antonella Notarnicola

  Anknuten till Forskning

  E-postadress antonella.notarnicola@ki.se
• Irene Peralta Garcia

  Anknuten till Forskning

  E-postadress irene.peralta.garcia@ki.se
• Henrik Pettersson

  Anknuten till Forskning

  E-postadress henrik.pettersson@ki.se
• Gloria Rostvall

  Biomedicinsk Analytiker

  E-postadress gloria.rostvall@ki.se
• Eleni Theofanidou Axelsson

  Doktorand

  E-postadress eleni.theofanidou.axelsson@ki.se
• 

  Robert Tonoian

  Anknuten till Forskning

  E-postadress robert.tonoian@ki.se
• Eveline Van Gompel

  Anknuten till Forskning

  E-postadress eveline.van.gompel.2@ki.se